News

The framework the new FDA leaders laid out on Tuesday raised small and big questions about the regulatory process, vaccine ...
A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make ...
The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the ...
Peter A. McCullough, a former cardiologist who promoted unproven treatments like ivermectin and hydroxychloroquine at the ...
After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...
Large, lengthy studies will be needed for the agency to approve boosters for healthy adults and children, regulators said.
Despite available vaccines and treatments, COVID-19 continues to cause an average of 350 deaths weekly in the U.S., according ...
Trump administration to restrict COVID vaccines to seniors and high-risk groups, pending more data for everyone else.